about
The structure of apo ArnA features an unexpected central binding pocket and provides an explanation for enzymatic cooperativityFrom Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale.The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria.Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility TestingDrugs of last resort? The use of polymyxins and tigecycline at US Veterans Affairs medical centers, 2005-2010.Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study.The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide.New Structural Templates for Clinically Validated and Novel Targets in Antimicrobial Drug Research and Development.Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin.Intravenous Colistin Use for Multidrug-Resistant Gram-Negative Infections in Pediatric PatientsImpact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosaMulticentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocolHow does colistin-induced nephropathy develop and can it be treated?Multidrug-Resistant Escherichia coli in Bovine Animals, EuropeNosocomial Acinetobacter baumannii Infections and Changing Antibiotic Resistance.Altered Outer Membrane Transcriptome Balance with AmpC Overexpression in Carbapenem-Resistant Enterobacter cloacaePolymyxins and analogues bind to ribosomal RNA and interfere with eukaryotic translation in vitro.Small Antimicrobial Agents Based on Acylated Reduced Amide Scaffold.Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenemsNebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients.Strategies for the safe use of colistin.Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacinImpairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.Potential synergy activity of the novel ceragenin, CSA-13, against carbapenem-resistant Acinetobacter baumannii strains isolated from bacteremia patients.Use of Colistin in a Neonatal Intensive Care Unit: A Cohort Study of 65 PatientsThe Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study.Polymyxin Resistance in Gram-negative Pathogens.Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.Evaluation of the synergistic effect of a combination of colistin and tigecycline against multidrug-resistant Acinetobacterbaumannii.Polymyxins Facilitate Entry into Mammalian Cells.Invitro Activities of Polymyxins and Rifampicin against Carbapenem Resistant Acinetobacter baumannii at a Tertiary Care Hospital from South India.Preparation and characterisation of the colistin-entrapped liposome driven by electrostatic interaction for intravenous administration.Unravelling of a mechanism of resistance to colistin in Klebsiella pneumoniae using atomic force microscopy.Molecular Mechanisms of Colistin Resistance in Klebsiella pneumoniae Causing Bacteremia from India-A First Report.[Multidrug-resistant bacteria in Germany. The impact of sources outside healthcare facilities].Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa.Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-β-lactamase-producing Escherichia coli in a foreign-body infection model.
P2860
Q27698393-F169D4A0-14BB-41E5-8728-557DE52BA6E5Q28552767-2F718F55-AEBA-4176-9266-2FA1D6DF833CQ30856181-DDE90A98-0679-4788-9602-EDF41D1770ACQ31140261-27013E9C-63C8-41A3-8F74-1CB758DD7872Q33817871-EC5F3835-2FF9-48F2-91BD-637C0A56C797Q34277350-849B995A-959B-4655-99C7-4B98CA1A09EFQ34552966-6F33FCE3-C35C-4E79-AA39-223D5B774C5EQ34955582-13C07ADA-A232-4A4F-8BEA-345EE36AACFCQ35120750-3F75E909-E9D1-49FC-82F7-5B60C0AB1564Q36153263-6A3505B2-E033-4984-902C-20F66D03B535Q36228369-5E6784D9-CA35-493D-94B4-4AD04F8E045BQ36229076-D3D4F5DA-DB04-4EDD-9E78-C23E306893CDQ36240813-0D958A0A-9969-45FA-BB10-1E723ACEBCECQ36818945-5B2E83EE-17F8-4279-9DED-3C16DAC1D264Q37036511-6E13DAAC-9AAA-4152-A0B1-89128CFC81D6Q37196241-8AD1F7AB-881E-422B-ABF9-7BCE9832C7EFQ37382724-C87A4719-FBEA-45F8-9A40-88B1613463F7Q37528489-C2DED732-716D-4FCB-AEF4-96ABA171BC29Q37626510-D548D016-67C9-42FB-AF1A-2F4D8763755FQ37692425-71473C83-5236-4C25-AE9D-F70F07894C23Q38126768-006EBC2E-92BF-4FBF-AE46-B1E7DE038A78Q38193537-0CDFA0A4-CDDC-43E9-9D22-BB4DCEC072B9Q38548658-8A805118-09FF-48A6-852C-713A50310DA8Q38634682-48A61A47-CD6C-43FC-9CD0-3664BB0045E5Q38741128-3EFCFE41-75A6-4B69-8C6C-0CB221B3B683Q38918568-C59DB510-B5EC-4926-ACEE-55328F9C530BQ38992007-FD3CA83B-2547-4499-94A7-215714912ABAQ39236424-0BC79DAF-E4C1-4889-8C3A-E71FE2DCABD7Q40051834-CF364D04-9262-4CCC-B84E-D8B4F6480F10Q40202934-4778C848-C990-4412-AB59-0827679650A6Q40206558-1C96B0AB-F7BE-45D3-90EF-DC4765DC810FQ40355863-93CE768A-A930-4E25-BDAF-685498DADE5FQ40478475-A5AB623A-113A-4968-8341-C3B524D3D0E7Q40621875-B924C75A-2383-4DB3-B750-1F44B8214A31Q40897433-C3B10568-963E-4A32-9611-2EF70150AEBEQ40962055-980D1C96-BAC4-4146-AC21-6DD6253F2FBFQ40962124-392DFD08-AB77-4630-9631-0BBC50FF3AB7Q41091116-3620B506-EE59-4B04-A8BE-338336C7E589Q41388208-B2233B9F-C8CF-4F7A-B14A-88EB2F8C50D8Q41453531-2630643D-02D5-4250-8B69-DE579F5A7673
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Colistin: new lessons on an old antibiotic.
@en
Colistin: new lessons on an old antibiotic.
@nl
type
label
Colistin: new lessons on an old antibiotic.
@en
Colistin: new lessons on an old antibiotic.
@nl
prefLabel
Colistin: new lessons on an old antibiotic.
@en
Colistin: new lessons on an old antibiotic.
@nl
P1476
Colistin: new lessons on an old antibiotic.
@en
P2093
P356
10.1111/J.1469-0691.2011.03734.X
P577
2012-01-01T00:00:00Z